Bleomycin-induced scleroderma: Report of a case with a chronic course rather than the typical acute/subacute self-limiting form

G. Passiu, A. Cauli, F. Atzeni, M. Aledda, G. Dessole, G. Sanna, P. Nurchis, A. Vacca, P. Garau, M. Laudadio, A. Mathieu

Research output: Contribution to journalArticlepeer-review

Abstract

We report a case of bleomycin-induced scleroderma in a 35-year-old woman treated with chemotherapy for Hodgkin's disease. Approximately 6 months after the first chemotherapy cycle, the patient developed skin sclerosis in both arms. The lesion showed no signs of spontaneous clinical amelioration and treatment with steroids was unsuccessful. A partial remission of the skin sclerosis was instead obtained by the administration of D-penicillamine. A family history revealed other cases of autoimmune diseases and HLA typing showed the presence of antigens associated with scleroderma. The association between bleomycin therapy and scleroderma is discussed.

Original languageEnglish
Pages (from-to)422-424
Number of pages3
JournalClinical Rheumatology
Volume18
Issue number5
DOIs
Publication statusPublished - 1999

Keywords

  • Bleomycin
  • Connective tissue disease
  • HLA
  • Scleroderma

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Fingerprint Dive into the research topics of 'Bleomycin-induced scleroderma: Report of a case with a chronic course rather than the typical acute/subacute self-limiting form'. Together they form a unique fingerprint.

Cite this